STAAR/$STAA
1D1W1MYTD1Y5YMAX
About STAAR
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
- Ticker
- $STAA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 921
- Headquarters
- Lake Forest, United States
- Website
- www.staar.com
STAAR Metrics
BasicAdvanced
$1.3B
340.36
$0.08
1.23
-
Price and volume
Market cap
$1.3B
Beta
1.23
52-week high
$35.87
52-week low
$15.59
Average daily volume
1M
Financial strength
Current ratio
4.665
Quick ratio
3.863
Long term debt to equity
8.146
Total debt to equity
9.836
Profitability
EBITDA (TTM)
49.764
Gross margin (TTM)
76.62%
Net profit margin (TTM)
1.13%
Operating margin (TTM)
12.15%
Effective tax rate (TTM)
77.91%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
5.65%
Return on equity (TTM)
1.09%
Valuation
Price to earnings (TTM)
340.358
Price to revenue (TTM)
3.848
Price to book
3.59
Price to tangible book (TTM)
3.95
Price to free cash flow (TTM)
-193.602
Free cash flow yield (TTM)
-0.52%
Free cash flow per share (TTM)
-0.135
Growth
Revenue change (TTM)
51.30%
Earnings per share change (TTM)
-103.98%
3-year revenue growth (CAGR)
3.54%
10-year revenue growth (CAGR)
15.58%
3-year earnings per share growth (CAGR)
-47.12%
10-year earnings per share growth (CAGR)
-13.38%
What the Analysts think about STAAR
Analyst ratings (Buy, Hold, Sell) for STAAR stock.
STAAR Financial Performance
Revenues and expenses
STAAR Earnings Performance
Company profitability
STAAR News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.